Abstract
Objective
There is continuing concern on the influence of hydroxethyl starch (HES) on renal function.
Design
Prospective, randomized study.
Setting
University-affiliated medical center.
Patients
Forty consecutive patients aged >70 years undergoing cardiac surgery using cardiopulmonary bypass.
Interventions
Either low-molecular HES (mean molecular weight: 130 kD) with low degree of substitution (0.4) (6% HES 130/0.4) (n=20) or gelatin (n=20) was given after induction of anesthesia until the 2nd postoperative day (POD) to keep central venous pressure between 12–14 mmHg.
Measurements and results
Creatinine clearance (CC) and fractional sodium clearance (FSC) were measured. N-acetyl-beta-D-glucosamidase , alpha-1-microglobulin , glutathione transferase-pi , and glutathione transferase-alpha were measured from urine specimens. Measurements were made after induction of anesthesia, at the end of surgery, and at the first and the second POD. More gelatin (total: 4150±490 ml) than HES 130/0.4 (total: 3450±450 ml) was infused within the study. CC and FSC were without differences between the two groups. All measured kidney-specific proteins were almost within normal range at baseline. They increased significantly after surgery, however, without significant group differences. At the 2nd POD, kidney-specific proteins had returned almost to normal values. None of the patients developed acute renal failure.
Conclusions
Sensitive markers of kidney dysfunction increased in our elderly patients indicating moderate alterations in kidney integrity during cardiac surgery. The two volume replacement regimens did not differ with regard to kidney integrity in elderly patients undergoing cardiac surgery.
Similar content being viewed by others
References
Marik PE, Iglesias J, Marini B (1997) Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 12:51–55
Mythen MG, Webb AR (1994) The role of gut mucosal hypoperfusion in the pathogenesis of postoperative organ dysfunction. Intensive Care Med 20:203–209
Warren BB, Durieux ME (1997) Hydroxyethylstarch: safe or not? Anesth Analg 84:206–212
Traylor RJ, Pearl R (1996) Crystalloid versus colloid: all colloids are not created equal. Anesth Analg 83:209–212
Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou C, Coriat P (1996) Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 348:1620–1622
Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicenter randomised study. Lancet 357:911–916
Peron S, Mouthon L, Guettier C, Brechignac S, Cohen P, Guillevin L (2001) Hydroxyethyl starch-induced renal insufficiency after plasma exchange in a patient with polymyositis and liver cirrhosis. Clin Nephrol 55:408–411
De Labarthe A, Jacobs F, Blot F, Glotz D (2001) Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 111:417–418
Ducke G, Briedis JH, Weaver RA (1994) Renal support in critically ill patients: low dose dopamine or low dose-dobutamine? Crit Care Med 22:1919–1925
Morgera S, Woydt R, Kern H, Schmutzler M, DeJonge K, Lun A, Rohde W, Konertz W, Kow WJ, Neumayer HM (2002) Low-dose prostacyclin preserves renal function in high-risk patients after coronary bypass surgery. Crit Care Med 30:107–112
Chew STH, Newman MF, White WD, Conlon PJ, Saunders AM, Strittmatter WJ, Landolfo K, Grocott HP, Stafford-Smith M (2000) Prelimary report on the association of apolipoprotein E polymorphisms, with postoperative peak serum creatinine concentrations in cardiac surgical patients. Anesthesiology 93:325–331
Kulka PJ, Tryba M, Zenz M (1996) Preoperative alpha-2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 24:947–952
Mangos GJ, Brown MA, Chan WY, Horton D, Trew P, Whitworth JA (1995) Acute renal failure following cardiac surgery: incidence, outcomes and risk factors. Aust N Z J Med 25:284–289
Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128:194–203
Chertow GM, Lazerus JM, Christiansen CL, Cook EF, Hammermeister KE, Grover F, Daley J (1997) Preoperative renal risk stratification. Circulation 95:878–884
Lindeman RD (1992) Changes in renal function with aging: implications for treatment. Drugs Aging 2:423–431
Jorres A, Kordonouri O, Schiessler A, Hess S, Farke S, Gahl GM, Muller C, Djurup R (1994) Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artif Organs 18:565–569
Westhuyzen J, McGiffin DC, McCarthy J, Fleming SJ (1994) Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228:123–132
Costa P, Ottino GM, Matani A, Pansini S, Canavese C, Passerini G, Grezzana G (1990) Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardithorac Anesth 4:469–473
Mantur M, Kemona H, Dabrowsky M, Dabrowska J, Sobolewski S, Prokopowicz J (2000) Alpha1-microglobulin as a marker of proximal tubular damage in urinary tract infection in children. Clin Nephrol 53:283–287
Sundberg AGM, Appelkvist EL, Bäckman L, Dallner G (1994) Quantitation of glutathione transferase-Pi in the urine by radioimmunaoassay. Nephron 66:162–169
Branten AJ, Mulder TP, Peters WH, Assmann KJ, Wetzels JF (2000) Urinary excretion of gluthatione S transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 85:120–126
Rahn KH (1991) Acute disturbances of renal function. Chest 100 [Suppl]:197S–199S
Ascione R, Lloyd CT, Underwood MJ (1999) On-pump versus off-pump cronary revascularization: evaluation of renal function. Ann Thorac Surg 68:493–498
Moran M, Kapsner C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150–153
Chinitz JL, Kim KE, Onesti G, Swartz C (1971) Pathophysiology and prevention of dextran-40-induced anuria. J Lab Clin Med 77:76–87
Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H (1993) Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 342:248–249
Iana A, Schwartz D (1994) Renal tubular cellular and molecular events in acute renal failure. Nephron 68:413–418
Jungheinrich C, Scharf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethylstarch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 95:544–551
Author information
Authors and Affiliations
Corresponding author
Additional information
This article has been retracted as the IRB approval for the research was misrepresented.
An erratum to this article is available at http://dx.doi.org/10.1007/s00134-011-2217-1.
About this article
Cite this article
Boldt, J., Brenner, T., Lehmann, A. et al. RETRACTED ARTICLE: Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of a new starch preparation with gelatin. Intensive Care Med 29, 763–769 (2003). https://doi.org/10.1007/s00134-003-1702-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-003-1702-6